Cite
HARVARD Citation
Bouder, F. (2008). Regulating impurities in pharmaceutical products: a tolerability of risk approach?. Expert review of clinical pharmacology. 1 (2), pp. 241-250. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bouder, F. (2008). Regulating impurities in pharmaceutical products: a tolerability of risk approach?. Expert review of clinical pharmacology. 1 (2), pp. 241-250. [Online].